arrow
N

Nathalie De Schrevel

pfizer united kingdom
H指数:10
被引数:1,187

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial

老年人1剂AS01E佐剂呼吸道合胞病毒前融合F蛋白疫苗的免疫原性和安全性: 3期试验

2023-12-149
OAAI
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains
2023-08-2311
PRE
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

呼吸道合胞病毒Prefusion F (RSVPreF3) 候选疫苗在老年人中的安全性和免疫原性: 1/2期随机临床试验

2022-07-2970
OAAI